Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Cytokinetics Inc

Cytokinetics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)51.00
  • Today's Change-0.31 / -0.60%
  • Shares traded989.44k
  • 1 Year change+46.30%
  • Beta0.7745
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Cytokinetics Inc (CYTK:NSQ) closed at 51.00, 66.23% above the 52 week low of 30.68 set on Nov 28, 2023.
52-week range
Today
30.68Nov 28 2023110.25Jan 08 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open51.04
High51.47
Low50.53
Bid50.15
Offer51.84
Previous close51.31
Average volume882.62k
Shares outstanding117.66m
Free float116.09m
P/E (TTM)--
Market cap6.04bn USD
EPS (TTM)-5.37
USD
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼

Events & Activity

  • CYTK:NSQ price moved over +1.81% to 52.25
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.